News | March 23, 2023
Emmes acquires Essex Management
Essex enriches and complements Emmes’ services
Essex enriches and complements Emmes’ services
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The companies will leverage their respective proprietary technology platforms
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
